68 results
8-K
EX-10.1
GHSI
Guardion Health Sciences, Inc.
15 Jul 24
Departure of Directors or Certain Officers
4:05pm
, reimbursement of business expenses, regular rate claims, and interest, damages, and promises on any and all of the above, but agrees that the Released Parties
DEFM14A
GHSI
Guardion Health Sciences, Inc.
8 Apr 24
Proxy related to merger
4:28pm
” means, without duplication and only to the extent incurred or subject to reimbursement by the Company and not paid prior to the Adjustment Time … party professional advisors including all brokerage fees, commissions, or finders’ fee incurred by (or subject to reimbursement by) the Company
PREM14A
GHSI
Guardion Health Sciences, Inc.
20 Mar 24
Preliminary proxy related to merger
8:15pm
in the computation of Working Capital.
“Transaction Expenses” means, without duplication and only to the extent incurred or subject to reimbursement … by (or subject to reimbursement by) the Company in connection with the Transactions, and (ii) any discretionary, transaction or change of control
425
EX-10.1
GHSI
Guardion Health Sciences, Inc.
31 Jan 24
Business combination disclosure
5:21pm
or subject to reimbursement by the Company and not paid prior to the Adjustment Time, whether accrued for or not, the collective amount of all (i) costs … , commissions, or finders’ fee incurred by (or subject to reimbursement by) the Company in connection with the Transactions, and (ii) any discretionary
8-K
EX-10.1
18y v3jikl
31 Jan 24
Entry into a Material Definitive Agreement
5:18pm
8-K
EX-10.1
ttmi4zpty4ro4 us
26 Sep 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
s7kt4o alumvzt
31 Jul 23
Departure of Directors or Certain Officers
5:20pm
8-K
EX-10.1
7do9msfniwwl69l1xllu
30 May 23
Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall
5:29pm
8-K
EX-10.1
odn p9n88
2 Dec 22
Entry into a Material Definitive Agreement
5:02pm
424B5
1aull1no61x a5nx3
24 Feb 22
Prospectus supplement for primary offering
4:30pm
8-K
EX-4.4
zudtj7x7
23 Feb 22
Guardion Health Sciences, Inc. Announces Proposed Public Offering
5:24pm
8-K
EX-10.1
kjs6pgwk 7tu4fyg9ymx
23 Feb 22
Guardion Health Sciences, Inc. Announces Proposed Public Offering
5:24pm
8-K
EX-10.2
blc50 umvmlkonkbi
23 Feb 22
Guardion Health Sciences, Inc. Announces Proposed Public Offering
5:24pm
424B5
ot9pxm
22 Feb 22
Prospectus supplement for primary offering
5:28pm
424B5
gru0uo4axl ttcm
17 Feb 22
Prospectus supplement for primary offering
8:30am
8-K
EX-10.1
50zrphid93yk1j8gr hp
2 Aug 21
Departure of Directors or Certain Officers
4:15pm